ScinoPharm Taiwan, Uni-President Enterprises Corp., Watson deal

Watson plans to divest its 31% equity ownership in active pharmaceutical ingredient (API) manufacturer ScinoPharm to Uni-President for $94 million. Watson said it has increased its own API development...